Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites
Tumor immunotherapy has now shown its promise for many, its disappointments and failings for others. Going forward, brain tumor patients can both benefit and contribute. Tumor immunotherapy is steadily progressing. As experience accumulates, it is important to consider its generality. The reviews he...
Saved in:
| Superior document: | Frontiers Research Topics |
|---|---|
| : | |
| Year of Publication: | 2018 |
| Language: | English |
| Series: | Frontiers Research Topics
|
| Physical Description: | 1 electronic resource (95 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993544303004498 |
|---|---|
| ctrlnum |
(CKB)4920000000094224 (oapen)https://directory.doabooks.org/handle/20.500.12854/49994 (EXLCZ)994920000000094224 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Lois A. Lampson auth Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites Immunotherapy for Tumor in the Brain Frontiers Media SA 2018 1 electronic resource (95 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Frontiers Research Topics Tumor immunotherapy has now shown its promise for many, its disappointments and failings for others. Going forward, brain tumor patients can both benefit and contribute. Tumor immunotherapy is steadily progressing. As experience accumulates, it is important to consider its generality. The reviews herein emphasize the brain’s place among other tumor sites. Two major topics are addressed. THE SITE: WHAT CAN WE EXPECT FROM IMMUNOTHERAPY WHEN THE TARGET IS IN THE BRAIN? Experience with immunotherapy for different targets in the brain, including tumor and also pathogens, is reviewed. Long-standing assumptions are confronted. The potential for beneficial responses is stressed. BRAIN TUMOR IMMUNOTHERAPY: WHAT HAVE WE LEARNED SO FAR? Clinical experience with brain tumor immunotherapy, from a variety of centers, is reviewed. Primary tumors, emphasizing glioblastoma, and brain metastases are each considered. English blood-brain barrier tumor antigen brain immunology glioblastoma brain tumor immunotherapy brain metastases brain tumor immune privilege 2-88945-535-1 |
| language |
English |
| format |
eBook |
| author |
Lois A. Lampson |
| spellingShingle |
Lois A. Lampson Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites Frontiers Research Topics |
| author_facet |
Lois A. Lampson |
| author_variant |
l a l lal |
| author_sort |
Lois A. Lampson |
| title |
Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites |
| title_full |
Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites |
| title_fullStr |
Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites |
| title_full_unstemmed |
Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites |
| title_auth |
Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites |
| title_alt |
Immunotherapy for Tumor in the Brain |
| title_new |
Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites |
| title_sort |
immunotherapy for tumor in the brain: insights from - and for - other tumor sites |
| series |
Frontiers Research Topics |
| series2 |
Frontiers Research Topics |
| publisher |
Frontiers Media SA |
| publishDate |
2018 |
| physical |
1 electronic resource (95 p.) |
| isbn |
2-88945-535-1 |
| illustrated |
Not Illustrated |
| work_keys_str_mv |
AT loisalampson immunotherapyfortumorinthebraininsightsfromandforothertumorsites AT loisalampson immunotherapyfortumorinthebrain |
| status_str |
n |
| ids_txt_mv |
(CKB)4920000000094224 (oapen)https://directory.doabooks.org/handle/20.500.12854/49994 (EXLCZ)994920000000094224 |
| carrierType_str_mv |
cr |
| hierarchy_parent_title |
Frontiers Research Topics |
| is_hierarchy_title |
Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites |
| container_title |
Frontiers Research Topics |
| _version_ |
1796651477347860480 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02051nam-a2200373z--4500</leader><controlfield tag="001">993544303004498</controlfield><controlfield tag="005">20231214133323.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2018 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000094224</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/49994</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000094224</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lois A. Lampson</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Immunotherapy for Tumor in the Brain</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (95 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Tumor immunotherapy has now shown its promise for many, its disappointments and failings for others. Going forward, brain tumor patients can both benefit and contribute. Tumor immunotherapy is steadily progressing. As experience accumulates, it is important to consider its generality. The reviews herein emphasize the brain’s place among other tumor sites. Two major topics are addressed. THE SITE: WHAT CAN WE EXPECT FROM IMMUNOTHERAPY WHEN THE TARGET IS IN THE BRAIN? Experience with immunotherapy for different targets in the brain, including tumor and also pathogens, is reviewed. Long-standing assumptions are confronted. The potential for beneficial responses is stressed. BRAIN TUMOR IMMUNOTHERAPY: WHAT HAVE WE LEARNED SO FAR? Clinical experience with brain tumor immunotherapy, from a variety of centers, is reviewed. Primary tumors, emphasizing glioblastoma, and brain metastases are each considered.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">blood-brain barrier</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor antigen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brain immunology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glioblastoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brain tumor immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brain metastases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brain tumor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune privilege</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88945-535-1</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:50:11 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337573520004498&Force_direct=true</subfield><subfield code="Z">5337573520004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337573520004498</subfield></datafield></record></collection> |